An interesting article about the FDA, business, potential conflicts of interest and hospital safety in “The Los Angeles Times” (March 1, 2015):

Scope maker Olympus faces scrutiny over patient deaths, infections” — click here.


“Olympus is almost like a bank that’s too big to fail now,” said hospital safety consultant Lawrence Muscarella, an expert on endoscopes who works near Olympus’ U.S. headquarters in Center Valley, Pa. “They’re brilliant, but I think they took too many risks.”

More to follow …

Posted: March 2, 2015, Rev A.

Leave a Reply

Your email address will not be published.